Glycopyrrolate Injection
Product Images NDC 86211-113

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Glycopyrrolate (NDC 86211-113). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Jvet Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton (Carton)

This text mentions a medication called Glycopyrrolate Injection, USP, which comes in 10x20 mL multiple dose vials. It is essential to note that this medication is not for use in newborns. The packaging contains benzyl alcohol. The text also includes instructions to pull a tab to open the packaging.*

FDA Label Image

Glycopyrrolate-spl-structural-formula (Glycopyrrolate Spl Structural Formula)

FDA Label Image

Label (Label)

This is information about Glycopyrrolate Injection, USP containing 4 mg/20 mL (0.2 mg/mL) with a warning that it should not be used in newborns and contains benzyl alcohol as a preservative. It is indicated for intramuscular or intravenous administration and comes in a 20 mL multiple-dose vial. The formulation includes water for injection, USP, benzyl alcohol, and pH adjusted with hydrochloric acid and/or sodium hydroxide. The usual dosage information is available in the package insert. It should be stored at 20°C to 25°C (68°F to 77°F). Distributed by Jvet Pharmaceuticals, LLC in Largo, Florida, USA, and manufactured in India.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.